ARCHIVES

Avastin For Adjuvant Treatment Of Colon Cancer Showed Benefit At One Year, But Failed Overall

This article is from The Cancer Letter archive.

Vol. 35 No. 22 | June 5, 2009

Download PDF Visit The Full Archive

Related Articles

In Multi-Site Phase I Studies, No Investigator Sees All Toxicities

March 26, 2010

Cancer Panel: Lack Of Genetic Basis For Race Presents Dilemma For Studies; Data Collection Must Include Socioeconomic Measures, Report To Clinton Says

March 20, 1998

Cooperative Group chairmen Cool, But High Priority Trials To Continue

January 18, 1991

Panel Debates Whether DCIS Needs A New Name

September 25, 2009

In Brief: NCI’s Katz Named Director, Arthritis Institute; Hayden Promoted At Bristol-Myers Squibb

July 14, 1995

Letter to the Editors: Society of Toxicology Comments On President’s Cancer Panel Report

August 6, 2010